Nasdaq - Delayed Quote
USD
Eventide Healthcare & Life Sciences C (ETCHX)
45.52
-0.83
(-1.79%)
At close: 8:01:07 PM EST
Fund Summary
Under normal market conditions, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. It may invest without limitation in securities of companies domiciled outside the United States either directly or through American Depositary Receipts ("ADRs"). The fund may invest in securities of companies of any market capitalization.
Eventide Healthcare & Life Sciences C
Willow Grove, PA19090
630-a Fitzwatertown Road 2nd Floor
Fund Overview
| Category | Health |
| Fund Family | Eventide Funds |
| Net Assets | 1.65B |
| YTD Return | 4.72% |
| Yield | 0.00% |
| Morningstar Rating | |
| Inception Date | Dec 27, 2012 |
Fund Operations
| Last Dividend | 0.28 |
| Last Cap Gain | 33.00 |
|---|---|
| Holdings Turnover | 87.00% |
| Average for Category | -- |
Fees & Expenses
| Expense | ETCHX | Category Average |
|---|---|---|
|
Annual Report Expense Ratio (net)
|
2.31% | 1.03% |
|
Prospectus Net Expense Ratio
|
2.31% | -- |
|
Prospectus Gross Expense Ratio
|
2.31% | -- |
|
Max 12b1 Fee
|
-- | -- |
|
Max Front End Sales Load
|
-- | 5.37% |
|
Max Deferred Sales Load
|
-- | 1.19% |
|
3 Yr Expense Projection
|
0 | -- |
|
5 Yr Expense Projection
|
0 | -- |
|
10 Yr Expense Projection
|
0 | -- |
Management Information
Morningstar Style Box
